Prostate Cancer
Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study.
January 12, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation.
January 12, 2024
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.
January 12, 2024
Non-invasive detection of neuroendocrine prostate cancer through targeted cell-free DNA methylation.
January 12, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
January 12, 2024
Clinical Positron Emission Tomography/Computed Tomography: Quarter-Century Transformation of Prostate Cancer Molecular Imaging.
January 12, 2024
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.
January 11, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.
January 11, 2024
Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer.
January 11, 2024
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer.
January 10, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.
January 10, 2024
A population-based study of cardiovascular disease mortality risk in US cancer patients.
January 10, 2024
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
January 10, 2024